Literature DB >> 24819719

Chemical approaches to targeting drug resistance in cancer stem cells.

Panagiota A Sotiropoulou1, Michael S Christodoulou2, Alessandra Silvani2, Christel Herold-Mende3, Daniele Passarella4.   

Abstract

Cancer stem cells (CSCs) are a subpopulation of cancer cells with high clonogenic capacity and ability to reform parental tumors upon transplantation. Resistance to therapy has been shown for several types of CSC and, therefore, they have been proposed as the cause of tumor relapse. Consequently, much effort has been made to design molecules that can target CSCs specifically and sensitize them to therapy. In this review, we summarize the mechanisms underlying CSC resistance, the potential biological targets to overcome resistance and the chemical compounds showing activity against different types of CSC. The chemical compounds discussed here have been divided according to their origin: natural, natural-derived and synthetic compounds.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24819719     DOI: 10.1016/j.drudis.2014.05.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  35 in total

1.  Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance.

Authors:  Gaia Fumagalli; Giulia Giorgi; Máté Vágvölgyi; Eleonora Colombo; Michael S Christodoulou; Veronica Collico; Davide Prosperi; Franco Dosio; Attila Hunyadi; Monica Montopoli; Mariafrancesca Hyeraci; Alessandra Silvani; Giordano Lesma; Lisa Dalla Via; Daniele Passarella
Journal:  ACS Med Chem Lett       Date:  2018-04-17       Impact factor: 4.345

Review 2.  Chemotherapy targeting cancer stem cells.

Authors:  Haiguang Liu; Lin Lv; Kai Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates.

Authors:  Gaia Fumagalli; Barbara Stella; Ievgenia Pastushenko; Francesca Ricci; Michael S Christodoulou; Giovanna Damia; Davide Mazza; Silvia Arpicco; Clelia Giannini; Lavinia Morosi; Franco Dosio; Panagiota A Sotiropoulou; Daniele Passarella
Journal:  ACS Med Chem Lett       Date:  2017-08-01       Impact factor: 4.345

4.  Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.

Authors:  Aaron M Kempema; John C Widen; Joseph K Hexum; Timothy E Andrews; Dan Wang; Susan K Rathe; Frederick A Meece; Klara E Noble; Zohar Sachs; David A Largaespada; Daniel A Harki
Journal:  Bioorg Med Chem       Date:  2015-05-30       Impact factor: 3.641

5.  Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells.

Authors:  Ming Liu; Weiyi Zhang; Wei Tang; Yanjuan Wang; Xingzeng Zhao; Xiangyun Wang; Xin Qi; Jing Li
Journal:  Tumour Biol       Date:  2015-09-02

6.  ent-Atisane diterpenoids from Euphorbia fischeriana inhibit mammosphere formation in MCF-7 cells.

Authors:  Xinzhu Kuang; Wei Li; Yuichiro Kanno; Naoya Yamashita; Kiyomitsu Nemoto; Yoshihisa Asada; Kazuo Koike
Journal:  J Nat Med       Date:  2015-09-28       Impact factor: 2.343

Review 7.  Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories.

Authors:  Anthony R Martin; Cyril Ronco; Luc Demange; Rachid Benhida
Journal:  Medchemcomm       Date:  2016-10-19       Impact factor: 3.597

Review 8.  ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.

Authors:  Cyril Ronco; Anthony R Martin; Luc Demange; Rachid Benhida
Journal:  Medchemcomm       Date:  2016-11-30       Impact factor: 3.597

Review 9.  The role of cancer stem cells in the modulation of anti-tumor immune responses.

Authors:  Cristina Maccalli; Kakil Ibrahim Rasul; Mamoun Elawad; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2018-09-24       Impact factor: 15.707

10.  Synergistic ultrasonic biophysical effect-responsive nanoparticles for enhanced gene delivery to ovarian cancer stem cells.

Authors:  Chun Liufu; Yue Li; Yan Lin; Jinsui Yu; Meng Du; Yuhao Chen; Yaozhang Yang; Xiaojing Gong; Zhiyi Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.